Tags |
|
|
Links |
|
|
E-Folder - Creating Partnership Agreements
Partnerships are essential in our emerging digital age.
Small pl
Small pl
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
ayers with good partnerships can grab precious market share from
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
arger,
established names. Digital commerce rewards innovation an
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
collaboration, not old buildings and traditions.
At the Westin
At the Westin
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
Hotel in Singapore, more than twenty framed certificates hang on
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
he wall announcing ‘Partnership Agreements’ with key customers an
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
suppliers.
Both parties agree to call upon one another as suppl
Both parties agree to call upon one another as suppl
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
ier or vendor of first choice, to provide new and special service
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
to each other before offering them to others, and to do all poss
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
ble to help build each other’s business.
The partnership program
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
is reinforced by continuous dialog, quarterly reviews, a partners
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
’ newsletter and other special events. Strong value flows both wa
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
s.
Key Learning Point
You can partner with customers, suppliers
Key Learning Point
You can partner with customers, suppliers
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
even your competitors. Instead of competition, use co-opetition.
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
Don't fight over the small pieces. Work together and make a bigg
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
r pie.
Action Steps
What are you doing to cultivate exceptional
Action Steps
What are you doing to cultivate exceptional
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
partnerships with your best customers and suppliers? Who can you
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
build a stronger partnership with this month: customers, supplier
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
, competitors, regulators, peers, employees or bosses? And what a
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
out your partnerships at home? The very same principles can apply
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.e-folder.org.ua/article/14877/e-folder-Creating-Partnership-Agreements.html">Creating Partnership Agreements</a>
BB link (for phorums):
[url=http://www.e-folder.org.ua/article/14877/e-folder-Creating-Partnership-Agreements.html]Creating Partnership Agreements[/url]
Related Articles:
The Perfect Franchise Opportunity: The Factors of the Art Workshop
Using Printed Mugs Effectively
The Smallest Intervention You Can Think Of
Bookmark it:
|